Massachusetts Gov. Deval Patrick to Visit Toxikon Corporation

September 15, 2011


Governor will address preclinical CRO’s employees and tour the Toxikon’s newly expanded Efficacy and Surgical Research services wing

BEDFORD, MA-SEPT. 15-2011--Toxikon, a preclinical contract research organization that provides product and technology development services to the biotechnology, pharmaceutical, and medical device industries, will host Massachusetts Gov. Deval Patrick on Tuesday, Sept. 20, at 10 a.m.

Along with addressing Toxikon employees, Gov. Patrick will tour Toxikon’s headquarters, including the newly expanded Efficacy and Surgical Research Services wing, a key resource for the pharmaceutical, biotech, medical device and combination product industries.ToxiconGov1

Dr. Laxman S. Desai, Toxikon’s President and CEO, says completion of work at the 25 Wiggins Avenue facility will provide Toxikon’s research and product development clientele with resources and scientific capabilities typically found only in hospital and academic settings.

“Our new and expanded capability for efficacy and surgical research not only reinforces our commitment to the development of tomorrow’s life saving medical devices and drugs, it also supports Gov. Patrick’s mission to make Massachusetts a global leader in the life sciences,” Dr. Desai said.

Gov. Patrick, who was named BIO Governor of the Year 2008 at the largest life science conference in the world, has said that he has made it his mission to make Massachusetts a global leader in life sciences.  Through the collaboration of industry, academia, business and government, the Patrick Administration says it is not only helping to find new cures and eradicate diseases, it is also creating many new jobs and investing in long-term economic growth.

“Massachusetts is rich in brainpower and research opportunities,” Gov. Patrick said.  “Our Administration is partnering with the life science industry, academia and the business community to capitalize on those resources, and is committed to building a sector dedicated to the innovation of novel therapies and medical devices for better healthcare and improved quality of life across the nation and the Commonwealth.”

For Toxikon Corporation, the parent company of Toxikon Europe in Leuven Belgium, the Bay State is an ideal place to be headquartered, Dr. Desai added.

“Massachusetts is unique because of its rich resource base,” he explained. “Life science industries, academia, the business community and local and state government are collectively committed to continually building a sector dedicated to the innovation of novel therapies and medical devices for better healthcare and improved quality of life.”

Toxikon Corp. was founded as Cambridge Diagnostics in 1977 and reincorporated to its current namesake in 1982, and despite the present economy, Dr. Desai says Toxikon is growing and hiring.

GOVToxicon tour


Along with providing career opportunities, Toxikon’s latest expansion to its ESRS wing will serve as a proving ground for tomorrow’s novel therapies and medical devices.

The facility will have the space for large and small animal models, and along with two vivaria, there are surgical and procedure spaces outfitted with the latest in surgical equipment, monitoring, and imaging equipment.

A fully staffed ESRS team will provide full hematological assessments, biochemistry, analytical, and pathology, and allows Toxikon to meet the efficacy and surgical service demands of Toxikon’s growing client base.

“Our facilities are also equipped to handle multiple surgical stations to accommodate physician trainings and demonstrations,” said Dr. Curtis Schondelmeyer, Toxikon’s Director of Preclinical Veterinary Services. “We can accommodate large groups and even provide remote visualization of procedures and surgeries within our facilities and around the world.”

The announcement of the new ESRS wing comes just months after Toxikon announced a new brand identity to reflect its comprehensive preclinical drug and device development capabilities.  Ultimately, the goal is reposition Toxikon as a key life science leader who can speed the advancement of therapeutic innovations for the treatment of disease andGovToxicon2 improvements in human health.

Toxikon has offered a range of services for novel device and drug development throughout its 34-year history.  “Our dedication to collaborating with sponsors; our capabilities to conduct standard and sponsor-specific programs; and our expertise and customer-centric focus put us in a unique position to accelerate product innovation, development, and commercialization,” Dr. Desai said. “Because of this, life science industries need to understand more about how Toxikon can complement and facilitate their development efforts.”


About Toxikon

Toxikon is a preclinical contract research organization. We contract and partner with biotech, pharmaceutical and medical device industries to deliver exceptional product development services from concept to final product.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.